Oral Hemorrhage
Cerebral Hemorrhage
Subarachnoid Hemorrhage
Intracranial Hemorrhages
Postpartum Hemorrhage
Gastrointestinal Hemorrhage
Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. (1/41)
An otherwise healthy elderly man developed massive, life-threatening, sublingual bleeding associated with an idiopathic factor VIII inhibitor. The patient was treated wtih cyclophosphamide, steroids, factor VIII concentrates, and repeated plasmapheresis (including three times with NCI-IBM blood-cell separator). Rapid clinical and laboratory improvement occurred, with complete disappearance of the inhibitor. The patient has remained well, without evidence of an inhibitor, for 8 mo. The possible role of each of the therapeutic measures in the disappearance of the inhibitor and the possible pathogenetic mechanism of this disorder are discussed. A high mortality rate and a striking incidence of sublingual hematoma have been observed in cases in the literature. (+info)Autogenous hard palate mucosa: the ideal lower eyelid spacer? (2/41)
BACKGROUND/AIMS: Raising a displaced lower eyelid frequently involves recession of the lower eyelid retractors with interposition of a "spacer," and several materials for this purpose have been described. This study reviewed the results of autogenous palatal mucosa in the treatment of lower eyelid displacement, including assessment of any donor site morbidity. METHODS: A retrospective case note review of consecutive patients treated at Moorfields Eye Hospital between 1993 and 1998. All patients underwent insertion of hard palate mucosa between the inferior border of the tarsus and the recessed conjunctiva and lower eyelid retractors. Parameters studied included the underlying diagnosis, measurements of lower lid displacement or retraction, related previous surgery, the experience of the operating surgeon, intraoperative and postoperative complications, surgical outcome, and length of follow up. The main outcome measure was the position of the lower eyelid relative to the globe in primary position of gaze. RESULTS: 102 lower eyelids of 68 patients were included and a satisfactory lid position was achieved in 87/102 (85%), with inadequate lengthening or significant recurrence of displacement occurring in 15 cases. Donor site haemorrhage requiring treatment in the early postoperative period occurred in seven patients (10%). CONCLUSION: Autogenous hard palate mucosa is an effective eyelid spacer and provides good long term support for the lower eyelid. Donor site complications are the main disadvantage, but may be minimised by attention to meticulous surgical technique and appropriate postoperative management. (+info)CT angiography before embolization for hemorrhage in head and neck cancer. (3/41)
We present a patient with advanced head and neck carcinoma and a bleeding pseudoaneurysm diagnosed by means of CT angiography; this was not apparent on conventional digital subtraction angiograms. The information provided by CT angiography facilitated rapid identification of the pseudoaneurysm and treatment with embolization. CT angiography may be helpful before embolization in cases of hemorrhage in head and neck cancer. (+info)Alveolar soft-part sarcoma of the tongue. (4/41)
Alveolar soft-part sarcoma is a rare, aggressive malignancy of uncertain histologic origin with a propensity for vascular invasion and distant metastasis. This neoplasm may mimic benign vascular neoplasms or malformations but careful evaluation of the unique imaging features on CT scans, MR images, and angiograms lead to the correct diagnosis. We present a case of alveolar soft-part sarcoma of the tongue and emphasize its radiologic and clinical features. (+info)Maximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach. (5/41)
This article reviews the use of nonsteroidal anti-inflammatory drugs (NSAIDs) for postoperative dental pain. An evidence-based approach is used to evaluate the clinical studies to date on the safe use of these drugs in dental patients. No drugs are without adverse effects or are perfectly safe, but their safe use in clinical practice would entail maximizing the therapeutic efficacy and minimizing the adverse effects. Therapeutic recommendations are made after reviewing the evidence for the safe use of NSAIDs in postoperative dental pain. (+info)Oral health is impaired in Behcet's disease and is associated with disease severity. (6/41)
OBJECTIVES: This study aimed to investigate the oral health of Turkish patients with Behcet's disease (BD) and whether it is associated with the disease course. METHODS: One hundred and twenty patients with BD, 35 patients with recurrent aphthous stomatitis (RAS) and 65 healthy Turkish controls (HC) were included in the study. Oral health was investigated by indices applied in a BD out-patient clinic. RESULTS: The mean scores of plaque, sulcus bleeding and gingival indices, probing depth and the number of extracted teeth were observed to be higher in patients with BD and RAS compared to HC (P<0.05). In the linear regression analysis, plaque index score was associated with the presence of oral ulcers and male gender. An elevated plaque index score was observed to be a significant risk factor for increased severity score in patients with BD in the logistic regression analysis (P = 0.034). CONCLUSIONS: Oral health is impaired in BD and associated with disease severity. Improvement of the oral health of BD patients may affect their disease course, leading to a better prognosis. (+info)Unusual post-extraction hemorrhage in a cardiac patient: a case report. (7/41)
In patients with cyanotic congenital heart disease (CCHD), the need for antibiotic prophylaxis for infective endocarditis is well known among dentists, but not many dentists are aware of the associated hemorrhagic tendencies in such patients. We report a case of post-extraction hemorrhage in a patient with Eisenmenger's syndrome and discuss the importance of more elaborate hematologic evaluation in patients with CCHD before oral surgery. (+info)A Stafne's cavity with unusual location in the mandibular anterior area. (8/41)
The typical Stafne's cavity, located on the posterior portion of the mandible, is a relatively uncommon entity. However, when the defect is located in the anterior region of the mandible, it is quite rare, having thus far been described in only 36 cases in the scientific literature. Most of these defects appear in the fifth and sixth decades of life, are localized to the area of the canines and premolars, and have a predilection for males. The inferior dental canal, one of the anatomical-radiographic landmarks that aid in the diagnosis of Stafne's cavity in the posterior region, is rarely present anterior the mental foramen. For this reason, because of its more variable radiographic appearance compared to the posterior defect, its tendency to be superimposed over the apices of the teeth, and the rarity of its localisation to the anterior mandible, it is much more difficult to establish a definitive diagnosis of a Stafne's cavity in this location. It is therefore more likely that a diagnostic error can occur, especially early on. We present a new case in a 68-year-old male in which the diagnosis was serendipitous, and we review in particular the aetiology and pathogenesis, clinical aspects, and differential diagnoses for this condition. (+info)Oral hemorrhage, also known as oral bleeding or mouth bleed, refers to the escape of blood from the blood vessels in the oral cavity, which includes the lips, gums, tongue, palate, and cheek lining. It can result from various causes such as trauma, dental procedures, inflammation, infection, tumors, or systemic disorders that affect blood clotting or cause bleeding tendencies. The bleeding may be minor and self-limiting, or it could be severe and life-threatening, depending on the underlying cause and extent of the bleed. Immediate medical attention is required for heavy oral hemorrhage to prevent airway obstruction, hypovolemia, and other complications.
Hemorrhage is defined in the medical context as an excessive loss of blood from the circulatory system, which can occur due to various reasons such as injury, surgery, or underlying health conditions that affect blood clotting or the integrity of blood vessels. The bleeding may be internal, external, visible, or concealed, and it can vary in severity from minor to life-threatening, depending on the location and extent of the bleeding. Hemorrhage is a serious medical emergency that requires immediate attention and treatment to prevent further blood loss, organ damage, and potential death.
A cerebral hemorrhage, also known as an intracranial hemorrhage or intracerebral hemorrhage, is a type of stroke that results from bleeding within the brain tissue. It occurs when a weakened blood vessel bursts and causes localized bleeding in the brain. This bleeding can increase pressure in the skull, damage nearby brain cells, and release toxic substances that further harm brain tissues.
Cerebral hemorrhages are often caused by chronic conditions like hypertension (high blood pressure) or cerebral amyloid angiopathy, which weakens the walls of blood vessels over time. Other potential causes include trauma, aneurysms, arteriovenous malformations, illicit drug use, and brain tumors. Symptoms may include sudden headache, weakness, numbness, difficulty speaking or understanding speech, vision problems, loss of balance, and altered level of consciousness. Immediate medical attention is required to diagnose and manage cerebral hemorrhage through imaging techniques, supportive care, and possible surgical interventions.
A subarachnoid hemorrhage is a type of stroke that results from bleeding into the space surrounding the brain, specifically within the subarachnoid space which contains cerebrospinal fluid (CSF). This space is located between the arachnoid membrane and the pia mater, two of the three layers that make up the meninges, the protective covering of the brain and spinal cord.
The bleeding typically originates from a ruptured aneurysm, a weakened area in the wall of a cerebral artery, or less commonly from arteriovenous malformations (AVMs) or head trauma. The sudden influx of blood into the CSF-filled space can cause increased intracranial pressure, irritation to the brain, and vasospasms, leading to further ischemia and potential additional neurological damage.
Symptoms of a subarachnoid hemorrhage may include sudden onset of severe headache (often described as "the worst headache of my life"), neck stiffness, altered mental status, nausea, vomiting, photophobia, and focal neurological deficits. Rapid diagnosis and treatment are crucial to prevent further complications and improve the chances of recovery.
Intracranial hemorrhage (ICH) is a type of stroke caused by bleeding within the brain or its surrounding tissues. It's a serious medical emergency that requires immediate attention and treatment. The bleeding can occur in various locations:
1. Epidural hematoma: Bleeding between the dura mater (the outermost protective covering of the brain) and the skull. This is often caused by trauma, such as a head injury.
2. Subdural hematoma: Bleeding between the dura mater and the brain's surface, which can also be caused by trauma.
3. Subarachnoid hemorrhage: Bleeding in the subarachnoid space, which is filled with cerebrospinal fluid (CSF) and surrounds the brain. This type of ICH is commonly caused by the rupture of an intracranial aneurysm or arteriovenous malformation.
4. Intraparenchymal hemorrhage: Bleeding within the brain tissue itself, which can be caused by hypertension (high blood pressure), amyloid angiopathy, or trauma.
5. Intraventricular hemorrhage: Bleeding into the brain's ventricular system, which contains CSF and communicates with the subarachnoid space. This type of ICH is often seen in premature infants but can also be caused by head trauma or aneurysm rupture in adults.
Symptoms of intracranial hemorrhage may include sudden severe headache, vomiting, altered consciousness, confusion, seizures, weakness, numbness, or paralysis on one side of the body, vision changes, or difficulty speaking or understanding speech. Rapid diagnosis and treatment are crucial to prevent further brain damage and potential long-term disabilities or death.
A retinal hemorrhage is a type of bleeding that occurs in the blood vessels of the retina, which is the light-sensitive tissue located at the back of the eye. This condition can result from various underlying causes, including diabetes, high blood pressure, age-related macular degeneration, or trauma to the eye. Retinal hemorrhages can be categorized into different types based on their location and appearance, such as dot and blot hemorrhages, flame-shaped hemorrhages, or subhyaloid hemorrhages. Depending on the severity and cause of the hemorrhage, treatment options may vary from monitoring to laser therapy, medication, or even surgery. It is essential to consult an ophthalmologist for a proper evaluation and management plan if you suspect a retinal hemorrhage.
Postpartum hemorrhage (PPH) is a significant obstetrical complication defined as the loss of more than 500 milliliters of blood within the first 24 hours after childbirth, whether it occurs vaginally or through cesarean section. It can also be defined as a blood loss of more than 1000 mL in relation to the amount of blood lost during the procedure and the patient's baseline hematocrit level.
Postpartum hemorrhage is classified into two types: primary (early) PPH, which occurs within the first 24 hours after delivery, and secondary (late) PPH, which happens between 24 hours and 12 weeks postpartum. The most common causes of PPH are uterine atony, trauma to the genital tract, retained placental tissue, and coagulopathy.
Uterine atony is the inability of the uterus to contract effectively after delivery, leading to excessive bleeding. Trauma to the genital tract can occur during childbirth, causing lacerations or tears that may result in bleeding. Retained placental tissue refers to the remnants of the placenta left inside the uterus, which can cause infection and heavy bleeding. Coagulopathy is a condition where the blood has difficulty clotting, leading to uncontrolled bleeding.
Symptoms of PPH include excessive vaginal bleeding, low blood pressure, increased heart rate, decreased urine output, and signs of shock such as confusion, rapid breathing, and pale skin. Treatment for PPH includes uterotonics, manual removal of retained placental tissue, repair of genital tract lacerations, blood transfusions, and surgery if necessary.
Preventing PPH involves proper antenatal care, monitoring high-risk pregnancies, active management of the third stage of labor, and prompt recognition and treatment of any bleeding complications during or after delivery.
Gastrointestinal (GI) hemorrhage is a term used to describe any bleeding that occurs in the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine, and rectum. The bleeding can range from mild to severe and can produce symptoms such as vomiting blood, passing black or tarry stools, or having low blood pressure.
GI hemorrhage can be classified as either upper or lower, depending on the location of the bleed. Upper GI hemorrhage refers to bleeding that occurs above the ligament of Treitz, which is a point in the small intestine where it becomes narrower and turns a corner. Common causes of upper GI hemorrhage include gastritis, ulcers, esophageal varices, and Mallory-Weiss tears.
Lower GI hemorrhage refers to bleeding that occurs below the ligament of Treitz. Common causes of lower GI hemorrhage include diverticulosis, colitis, inflammatory bowel disease, and vascular abnormalities such as angiodysplasia.
The diagnosis of GI hemorrhage is often made based on the patient's symptoms, medical history, physical examination, and diagnostic tests such as endoscopy, CT scan, or radionuclide scanning. Treatment depends on the severity and cause of the bleeding and may include medications, endoscopic procedures, surgery, or a combination of these approaches.
A Vitreous Hemorrhage is a medical condition where there is bleeding into the vitreous cavity of the eye. The vitreous cavity is the space in the eye that is filled with a clear, gel-like substance called the vitreous humor. This substance helps to maintain the shape of the eye and transmit light to the retina.
When a vitreous hemorrhage occurs, blood cells from the bleeding mix with the vitreous humor, causing it to become cloudy or hazy. As a result, vision can become significantly impaired, ranging from mildly blurry to complete loss of vision depending on the severity of the bleed.
Vitreous hemorrhages can occur due to various reasons such as trauma, retinal tears or detachments, diabetic retinopathy, age-related macular degeneration, and other eye conditions that affect the blood vessels in the eye. Treatment for vitreous hemorrhage depends on the underlying cause and may include observation, laser surgery, or vitrectomy (a surgical procedure to remove the vitreous humor and stop the bleeding).
An eye hemorrhage, also known as subconjunctival hemorrhage, is a condition where there is bleeding in the eye, specifically under the conjunctiva which is the clear membrane that covers the white part of the eye (sclera). This membrane has tiny blood vessels that can rupture and cause blood to accumulate, leading to a visible red patch on the surface of the eye.
Eye hemorrhages are usually painless and harmless, and they often resolve on their own within 1-2 weeks without any treatment. However, if they occur frequently or are accompanied by other symptoms such as vision changes, pain, or sensitivity to light, it is important to seek medical attention as they could indicate a more serious underlying condition. Common causes of eye hemorrhages include trauma, high blood pressure, blood thinners, and aging.